BEIJING, Dec. 6, 2010 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced its participation in the 29th Annual J.P. Morgan Healthcare Conference, to be held January 10-13, 2011 at the Westin St. Francis Hotel in San Francisco. The China Healthcare Track of the conference will be held on January 12, 2010. Management will meet with institutional investors throughout the duration of the conference.
For further details, please contact your J.P. Morgan institutional sales representative.
About China Nuokang Bio-Pharmaceutical Inc.
China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) is a leading biopharmaceutical company in China focused on the research, development, manufacture, marketing and sales of hospital-based medical products. The Company provides a diversified portfolio of products across more than 2,400 hospitals in China. Nuokang's principal products include Baquting®, China's leading hemocoagulase product by market share, Kaitong®, a cardiocerebral and peripheral vascular product, and Aiduo®, a cardiovascular stress imaging agent. The Company's product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. Please visit www.nkbp.com for more information.
CONTACT: ICR, LLC In the U.S.: Ashley M. Ammon Christine Duan 1-646-277-1227 In China: Wen Lei Zheng 86-10-6583-7510